Dermata Therapeutics, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

v3.25.1

Insider Trading Arrangements	12 Months Ended
Insider Trading Arrangements	Dec. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangements Adopted [Flag	false
Rule 10b5-1 Arrangements Terminated [Flag]	false
Non Rule 10b5-1 Arrangements Adopted [Flag]	false
Non Rule 10b5-1 Arrangements Terminated [Flag]	false

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 408
-Subsection a

Name:	ecd_InsiderTradingArrLineItems
Namespace Prefix:	ecd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 408
-Subsection a
-Paragraph 1

Name:	ecd_NonRule10b51ArrAdoptedFlag
Namespace Prefix:	ecd_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 408
-Subsection a
-Paragraph 1

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 408
-Subsection a
-Paragraph 1

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 408
-Subsection a
-Paragraph 1